RheumaGen

0 followers


RheumaGen is a gene-editing technology developing therapeutics to cure rheumatoid arthritis. It offers an HLA gene-editing platform that uses stem-cell-enriched blood to alter DNA to suppress the immune system and stop rheumatoid arthritis's abnormal immune response.

Industries

Headquarters

Denver, US

Employees

1-10

Links

Org chart

Richard Freed
Chief Executive Officer

Richard Freed

Collapse
Brian Hart
Co-Founder & Chief Operating Officer
Ryan H.
Chief Legal Officer
Tate Hermanson
VP of Finance

Teams

This company has no teams yet